Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|December 22, 2016
Targeting delta opioid receptors for pain treatment: drugs in phase I and II clinical developmentViola Spahn, Christoph SteinMolecular Pharmacology|November 27, 2013
Modulation of transient receptor vanilloid 1 activity by transient receptor potential ankyrin 1Viola Spahn, Christoph Stein, Christian ZöllnerMethods in Molecular Biology (Clifton, N.J.)|October 9, 2014
Analysis of potassium and calcium imaging to assay the function of opioid receptorsViola Spahn, Dinah Nockemann, Halina MachelskaMethods in Molecular Biology (Clifton, N.J.)|October 9, 2014
Electrophysiological patch clamp assay to monitor the action of opioid receptorsViola Spahn, Dinah Nockemann, Halina MachelskaACS Chemical Neuroscience|June 13, 2017
Novel Opioid Analgesics and Side EffectsGiovanna Del Vecchio, Viola Spahn, Christoph SteinNeuropharmacology|October 11, 2015
Opioids and TRPV1 in the peripheral control of neuropathic pain--Defining a target site in the injured nerveDominika Labuz, Viola Spahn, Melih Özgür Celik, et al.Frontiers in Pharmacology|January 9, 2019
Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons - Effects of Nerve InjuryPhilip Stötzner, Viola Spahn, Melih Ö Celik, et al.Pain|July 12, 2018
Analgesic effects of a novel pH-dependent μ-opioid receptor agonist in models of neuropathic and abdominal painAntonio Rodriguez-Gaztelumendi, Viola Spahn, Dominika Labuz, et al.Biotechnology and Bioengineering|June 3, 2017
Production of G protein-coupled receptors in an insect-based cell-free systemAndrei Sonnabend, Viola Spahn, Marlitt Stech, et al.Pain|February 13, 2013
Opioid withdrawal increases transient receptor potential vanilloid 1 activity in a protein kinase A-dependent mannerViola Spahn, Oliver Fischer, Jeannette Endres-Becker, et al.Pageof 2